Apogee Therapeutics shareholders elect three Class I directors, ratify auditor, approve option grant

Apogee Therapeutics, Inc.

Elected Andrew Gottesdiener, Peter Harwin, and Michael Henderson as Class I directors with >33.8M votes for each.
Ratified Ernst & Young as independent auditor for FY 2024 with 41.56M votes for, 2,163 against.
Approved grant of options for 100,000 shares to a director with 40.43M votes for, 330,671 against.
All proposals passed with broker non-votes of 805,441 on director election and option grant.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.